Eradication rate | TBQT group (n = 182) | LBQT group (n = 182) | P value |
---|
ITT analysis | 163/182 (89.6%) | 118/182 (64.8%) | < 0.001 |
PP analysis | 163/179 (91.1%) | 118/174 (67.8%) | < 0.001 |
- TBQT tailored, bismuth-based quadruple therapy, amoxicillin + levofloxacin or furazolidone + esomeprazole + colloidal bismuth pectin, LBQT levofloxacin- and bismuth-based quadruple therapy. amoxicillin + levofloxacin + esomeprazole + colloidal bismuth pectin, ITT intention‐to‐treat, PP per protocol